Year |
Citation |
Score |
2021 |
Oh JH, Lee HW, Sinn DH, Park JY, Kim BK, Kim SU, Kim DY, Ahn SH, Kang W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Paik YH. Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy. Hepatology International. PMID 34260013 DOI: 10.1007/s12072-021-10205-7 |
0.302 |
|
2021 |
Na JE, Sinn DH, Lee JH, Jang HJ, Baek SY, Kim KA, Kang W, Gwak GY, Paik YH, Kim YJ, Choi MS, Yoon JH, Hyeok Lee J, Koh KC, Paik SW. Efficacy of entecavir vs tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response. Journal of Viral Hepatitis. PMID 34251707 DOI: 10.1111/jvh.13572 |
0.3 |
|
2018 |
Song BG, Sinn DH, Chi S, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy. European Journal of Gastroenterology & Hepatology. PMID 30063482 DOI: 10.1097/MEG.0000000000001226 |
0.321 |
|
2017 |
Oh IS, Sinn DH, Kang TW, Lee MW, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Digestive Diseases and Sciences. PMID 28983724 DOI: 10.1007/s10620-017-4775-8 |
0.307 |
|
2017 |
Paik N, Sinn DH, Lee JH, Oh IS, Kim JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low level viremia. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 28581248 DOI: 10.1111/liv.13489 |
0.309 |
|
2016 |
Kim JH, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment. Hepatology (Baltimore, Md.). PMID 28012257 DOI: 10.1002/hep.28916 |
0.312 |
|
2016 |
Sinn DH, Lee JH, Kim K, Ahn JH, Lee JH, Kim JH, Lee DH, Yoon JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels. Gut and Liver. PMID 27980231 DOI: 10.5009/gnl16403 |
0.309 |
|
2014 |
Sohn W, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Annals of Surgical Oncology. 21: 2429-35. PMID 24619495 DOI: 10.1245/s10434-014-3621-x |
0.306 |
|
2014 |
Sohn W, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation. Scandinavian Journal of Gastroenterology. 49: 373-80. PMID 24354931 DOI: 10.3109/00365521.2013.871745 |
0.301 |
|
2012 |
Bae SY, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area. Clinical and Molecular Hepatology. 18: 185-94. PMID 22893869 DOI: 10.3350/cmh.2012.18.2.185 |
0.307 |
|
Show low-probability matches. |